Article from the hearld Sun ...
/www.heraldsun.com.au/ipad-application/keeping-it-small-just-makes-sense/story-fn6bn4mv-1225964129948"> https://www.heraldsun.com.au/ipad-application/keeping-it-small-just-makes-sense/story-fn6bn4mv-1225964129948">
https://www.heraldsun.com.au/ipad-application/keeping-it-small-just-makes-sense/story-fn6bn4mv-1225964129948
"In a somewhat bizarre move that shows how the world has shrunk, asuccessful but underappreciated Canadian biotechnology company is aboutto also list on the Australian Securities Exchange.
Bioniche has agreat track record of developing and selling more than 60 animal healthproducts for companion animals, livestock and horses.
However,even that business has struggled to provide enough cash to fund thedevelopment of its breakthrough human bladder cancer drug Urocidin.
Australian-bornchief executive, Graeme McRae, said Urocidin's potential was so strongthat US healthcare company Endo Pharmaceuticals had signed a globallicence, development and supply agreement to help fund final phase threetests.
Bladder cancer is the fourth most common cancer in men andthe 11th in women and current treatments are old and have many sideeffects, which should provide a ready market for Urocidin.
The drug also shows significant promise in treating other cancers.
Graemesaid up to 20 million new shares are on offer in Canada and Australiato raise $30 million. Vets in both countries are being sent theprospectus."